$16.86
0.82% day before yesterday
Nasdaq, Apr 04, 10:00 pm CET
ISIN
US3596641098
Symbol
FLGT

Fulgent Genetics Target price 2025 - Analyst rating & recommendation

Fulgent Genetics Classifications & Recommendation:

Buy
33%
Hold
67%

Fulgent Genetics Price Target

Target Price $20.00
Price $16.86
Potential
Number of Estimates 3
3 Analysts have issued a price target Fulgent Genetics 2026 . The average Fulgent Genetics target price is $20.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 1 Analysts recommend Fulgent Genetics to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Fulgent Genetics stock has an average upside potential 2026 of . Most analysts recommend the Fulgent Genetics stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 283.47 310.44
1.98% 9.51%
EBITDA Margin -17.28% -6.74%
14.80% 61.00%
Net Margin -15.34% -20.17%
74.45% 31.49%

3 Analysts have issued a sales forecast Fulgent Genetics 2025 . The average Fulgent Genetics sales estimate is

$310m
Unlock
. This is
9.51% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$311m 9.70%
Unlock
, the lowest is
$310m 9.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $283m 1.98%
2025
$310m 9.51%
Unlock
2026
$341m 9.90%
Unlock
2027
$370m 8.59%
Unlock

3 Analysts have issued an Fulgent Genetics EBITDA forecast 2025. The average Fulgent Genetics EBITDA estimate is

$-20.9m
Unlock
. This is
57.31% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-6.0m 87.75%
Unlock
, the lowest is
$-31.4m 35.84%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-49.0m 12.52%
2025
$-20.9m 57.31%
Unlock
2026
$-13.8m 34.17%
Unlock
2027
$-705k 94.88%
Unlock

EBITDA Margin

2024 -17.28% 14.80%
2025
-6.74% 61.00%
Unlock
2026
-4.03% 40.21%
Unlock
2027
-0.19% 95.29%
Unlock

1 Analyst has issued a net profit forecast Fulgent Genetics 2025 . The average Fulgent Genetics net profit estimate is

$-62.6m
Unlock
. This is
42.97% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-62.6m 42.97%
Unlock
, the lowest is
$-62.6m 42.97%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-43.5m 74.96%
2025
$-62.6m 43.98%
Unlock
2026
$-64.2m 2.46%
Unlock

Net Margin

2024 -15.34% 74.45%
2025
-20.17% 31.49%
Unlock
2026
-18.80% 6.79%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.41 -2.03
74.96% 43.97%
P/E negative
EV/Sales 0.86

1 Analysts have issued a Fulgent Genetics forecast for earnings per share. The average Fulgent Genetics EPS is

$-2.03
Unlock
. This is
42.96% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-2.03 42.96%
Unlock
, the lowest is
$-2.03 42.96%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.41 74.96%
2025
$-2.03 43.97%
Unlock
2026
$-2.08 2.46%
Unlock

P/E ratio

Current -11.91 209.35%
2025
-8.31 30.23%
Unlock
2026
-8.11 2.41%
Unlock

Based on analysts' sales estimates for 2025, the Fulgent Genetics stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.94 16.05%
2025
0.86 8.35%
Unlock
2026
0.78 9.01%
Unlock
2027
0.72 7.91%
Unlock

P/S ratio

Current 1.84 17.85%
2025
1.68 8.69%
Unlock
2026
1.53 9.00%
Unlock
2027
1.40 7.91%
Unlock

Current Fulgent Genetics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Piper Sandler
Locked
Locked
Locked Mar 04 2025
Piper Sandler
Locked
Locked
Locked Nov 11 2024
Analyst Rating Date
Locked
Piper Sandler:
Locked
Locked
Mar 04 2025
Locked
Piper Sandler:
Locked
Locked
Nov 11 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today